APA (7th ed.) Citation

B, H., P, R., J, M., X, H., D, C., M, S., & B, Z. (2024). Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors. Frontiers in oncology, 14, 1285280. https://doi.org/10.3389/fonc.2024.1285280

Chicago Style (17th ed.) Citation

B, Halmos, Rai P, Min J, Hu X, Chirovsky D, Shamoun M, and Zhao B. "Real-world Outcomes on Platinum-containing Chemotherapy for EGFR-mutated Advanced Nonsquamous NSCLC with Prior Exposure to EGFR Tyrosine Kinase Inhibitors." Frontiers in Oncology 14 (2024): 1285280. https://doi.org/10.3389/fonc.2024.1285280.

MLA (9th ed.) Citation

B, Halmos, et al. "Real-world Outcomes on Platinum-containing Chemotherapy for EGFR-mutated Advanced Nonsquamous NSCLC with Prior Exposure to EGFR Tyrosine Kinase Inhibitors." Frontiers in Oncology, vol. 14, 2024, p. 1285280, https://doi.org/10.3389/fonc.2024.1285280.